The BioZorb Marker, a medical device implanted during breast cancer surgery to help guide radiation therapy, has been linked to serious complications that put patients at risk.
The U.S. Food and Drug Administration (FDA) has issued a safety communication warning healthcare providers and patients not to use BioZorb due to its potential to migrate within the body or erode into surrounding tissue. These dangerous defects have led to painful complications, infections, and the need for additional surgeries to remove the device.
At Ferrer Poirot Feller, we believe it’s unacceptable when medical device manufacturers release dangerous products into the market, and we work hard to hold them accountable when those products injure patients. If you or someone you love was harmed by a BioZorb Marker and needed (or currently need) surgery to remove it, we’re on your side. Contact us today for a free consultation.
What Is the BioZorb Marker?
The BioZorb Marker is an implantable device designed for use in soft tissue sites, including breast tissue. It consists of two components: a plastic structure meant to dissolve in a year or longer, and a titanium component intended to remain permanently.
The device is primarily used to provide radiographic marking for soft tissue sites while serving as a reference for future medical procedures. Despite its intended purpose, the BioZorb Marker has been linked to severe complications, including migration from its original placement and erosion into surrounding tissue.
BioZorb Migration and Erosion Can Lead to Severe Complications
BioZorb Markers were intended to provide a long-term surgical reference point after lumpectomy procedures. However, patients have reported cases where the device shifts from its original placement, embedding itself in unintended areas. Migration can lead to:
- Severe pain and discomfort
- Damage to nearby organs and tissue
- Inflammation and infection
- Difficulties in future imaging and treatment
Erosion is another significant concern. The device has been found to break through skin or other tissue, causing open wounds, severe irritation, and increased risks of infection. Many patients experiencing these issues have required invasive procedures or emergency surgeries to remove the defective Marker.
FDA Warning: BioZorb No Longer Considered Safe
On Feb. 16, 2024, the FDA warned doctors, surgeons, and other healthcare providers against using BioZorb Markers due to reports of severe complications.
The agency advised healthcare providers to stop implanting the device immediately and recommended that patients experiencing pain, swelling, or unusual symptoms seek medical attention. This follows numerous adverse event reports submitted to the FDA that show an alarming trend of migration, erosion, and surgical complications.
Were You Harmed by a BioZorb Marker? We Can Help.
If you or a loved one received a BioZorb Marker and suffered from painful complications, you may be eligible for compensation for your damages. At Ferrer Poirot Feller, we fight for patients harmed by defective medical devices and can help you get maximum compensation for:
- Medical expenses for removal surgeries and treatments
- Pain and suffering from Marker-related complications
- Lost wages due to recovery time and disability
- Other damages related to the defective device
Contact Us for a Free Consultation
You shouldn’t have to suffer because of a defective medical device.
If you’ve experienced migration, erosion, or other complications from a BioZorb Marker and required surgery or have a planned surgery to remove the device, our legal team is ready to help. Contact Ferrer Poirot Feller today for a free case review and learn how we can fight for the compensation you deserve.